Under construction – not a live service
Sign in
Not yet taking people in United StatesPhase 1

Tests gentle focused ultrasound for autism in young people

Tests a non-invasive ultrasound device aimed at the thalamus in people with autism.

Plain-language title generated from the registry record
Registry title: Low Intensity Focused Ultrasound in ASD

Key facts

Where
Charleston, United StatesSee the site
Phase
Phase 1

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 13 and 25 years old?

Source: NCT07225322, who can take part

Where in United States

  • MUSC Brain Stimulation OfficesCharleston, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Medical University of South Carolina
Trial code
NCT07225322
Record updated
22 May 2026
Original description
This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.Read full original descriptionShow less

Low Intensity Focused Ultrasound in Autism Spectrum Disorder

This study investigates the safety and potential efficacy of personalized, image-guided low intensity focused ultrasound (LIFU) targeting the thalamus in individuals with Autism Spectrum Disorder (ASD). The study evaluates behavioral, neuroimaging, and electrophysiological outcomes following LIFU stimulation using a non-invasive device.

Inclusion: Age 13-25; Diagnosis of ASD (DSM-5); Full Scale IQ > 70; Verbal communication; Stable medication for ≥1 month; Ability to consent or assent with guardian consent.

Exclusion: Recent investigational drug/device use; Neurological illness (e.g., epilepsy, TBI); Substance use disorder; MRI or LIFU contraindications; Sensory/motor impairments preventing task completion.

ClinicalTrials.gov NCT07225322